S Barnass, J Franklin, S Tabaqchali. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAdultAgedCiprofloxacin/administration & dosageCiprofloxacin/therapeutic useDrug Resistance, MicrobialFeces/microbiologyFemaleHumansMaleMiddle AgedSalmonella/drug effectsSalmonella Infections/drug therapySalmonella Infections/microbiologySalmonella Infections/urine
Substances: See more » Ciprofloxacin
Year: 1990 PMID: 2329107 DOI: 10.1093/jac/25.2.299
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790